Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01819844 · ClinicalTrials.gov registry record · NA
Inpatient Closed-loop Glucose Control
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01819844: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01819844 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01819844, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to test an experimental medical device designed to automatically control blood sugar. This device was designed for use by patients with diabetes while they are in the hospital, and others who may develop high blood sugar as a result of their medical problems.
Interventions
- DEVICE Closed-loop blood glucose control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01819844
The ClinicalTrials.gov registry entry for NCT01819844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Closed-loop blood glucose control is the first listed.
NCT01819844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01819844 about?
NCT01819844 is a clinical study titled "Inpatient Closed-loop Glucose Control". The purpose of this study is to test an experimental medical device designed to automatically control blood sugar. This device was designed for use by patients with diabetes while they are in the hospital, and others who may develop high blood sugar as a result of their medical problems.
What is the current status of trial NCT01819844?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-03. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01819844?
The interventions under investigation include: Closed-loop blood glucose control (DEVICE).
Who is sponsoring clinical trial NCT01819844?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.